FI
ALDR

Fosun International’s Alder Biopharmaceuticals ALDR Stock Holding History

Fosun International’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-233,858
Closed -$2.64M – 333
2019
Q2 		$2.64M Hold
233,858
– – 0.17% 86
2019
Q1 		$3.11M Buy
233,858
+49,045
+27% +$635K 0.2% 68
2018
Q4 		$1.89M Buy
184,813
+25,000
+16% +$320K 0.11% 90
2018
Q3 		$2.66M Buy
+159,813
New +$2.89M 0.13% 73

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fosun International's ALDR Position: Q3 2019 in Review

Fosun International sold out of Alder Biopharmaceuticals (ALDR) in Q3 2019, closing a stake of 233,858 shares — an estimated $2.64M sold.

Fosun International first reported a position in ALDR in Q3 2018 and held it in 4 quarters. The position peaked at $3.11M in Q1 2019. 143 funds tracked by Wall St. Rank hold ALDR as of Q3 2019.

  • Fosun International reported no remaining Alder Biopharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 233,858 Alder Biopharmaceuticals shares in Q3 2019, an estimated $2.64M.
  • Fosun International first reported a position in Alder Biopharmaceuticals in Q3 2018 and held it in 4 quarters.
  • Fosun International's Alder Biopharmaceuticals position peaked at $3.11M in Q1 2019.
  • 143 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.